Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2010
02/11/2010CA2731897A1 Diazepine and diazocane compounds as mc4 agonists
02/11/2010CA2731494A1 Process for the preparation of nicotine-based haptens
02/11/2010CA2731368A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
02/10/2010EP2151439A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
02/10/2010EP2150546A2 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
02/10/2010EP2150543A2 Heterocyclic compounds with affinity to muscarinic receptors
02/10/2010EP2150539A1 Pyridazinone derivatives
02/10/2010EP2150534A1 Isoquinolinone derivatives as nk3 antagonists
02/10/2010EP2150255A1 Quinoxaline derivatives as p13 kinase inhibitors
02/10/2010EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1701951B1 Modulators of peripheral 5-ht receptors
02/10/2010CN101646665A 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
02/10/2010CN101643469A Synthesis process of barnidipine hydrochloride
02/10/2010CN101643468A Quinolinone alkaloid derivant as well as preparation method and application thereof
02/09/2010US7659408 Especially in which the amide nitrogen is substituted with an adamantyl group, e.g., N-adamantyl-4-chloro-5-(o-fluorophenyl)-1-methyl-3-pyrazolecarboxamide; treating hyperglycemia, diabetes or insulin resistance
02/09/2010US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds
02/09/2010US7659401 Thiazolo[4,5-C]pyridine derivatives
02/09/2010US7659307 Heterocyclic carboxamides and their use as fungicides
02/09/2010US7659305 4-carbo- or heterocyclic alkyl-, oxy-, amino-, and thio-substituted; e.g., 2S, 4S)-4-(3-Chloro-phenoxy)-pyrrolidine-2-carboxylic acid; controlling neurotransmitter release; uses include general treatment of pain, particularly neuropathic pain.
02/09/2010US7659298 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting
02/09/2010US7659288 5-aminoalkylpyrazole derivatives as pesticidal agents
02/09/2010US7659276 1-{[1-(2,6-dimethylphenyl)-1H-tetrazol-5-yl]phenylmethyl}-4-(3-phenylallyl)piperazine; G-protein coupled receptor antagonist; antidepressant, anxiolitic agent, obesity
02/09/2010US7659275 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
02/09/2010US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders
02/09/2010US7659268 Modulators of ATP-binding cassette transporters
02/09/2010US7659228 Synergistic insecticide mixtures
02/09/2010CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
02/09/2010CA2451962C Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
02/09/2010CA2451562C Piperazine compound
02/09/2010CA2451240C Cyclic diamine compound with 6 membered ring groups
02/09/2010CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2375201C Crystal of (r)-lansoprazole
02/09/2010CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
02/09/2010CA2299754C Hydroxy-substituted n-alkoxy hindered amines
02/09/2010CA2274201C Di-or triaza-spiro[4,5]decane derivatives
02/09/2010CA2268403C Anthranilic acid derivatives as multi drug resistance modulators
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/04/2010WO2010014280A1 Pyrazinone modulator of corticotropin-releasing factor receptor activity
02/04/2010WO2010014022A1 A process for the preparation of imatinib
02/04/2010WO2010013849A1 Gpr119 agonist
02/04/2010WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
02/04/2010WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents
02/04/2010WO2010013161A1 Fluorinated heteroaryls
02/04/2010WO2010012797A2 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives
02/04/2010WO2010012747A1 New compounds
02/04/2010WO2010012740A1 5-alkynyl-pyrimidines
02/04/2010WO2010012649A1 Piperazine compounds with herbicidal effect
02/04/2010WO2010012619A1 Diazepan and piperazine derivatives modulators of chemokine receptors
02/04/2010WO2010012466A1 Antitumor properties of no modified protease inhibitors
02/04/2010WO2010012442A2 Insecticidal benzenedicarboxamide derivative
02/04/2010WO2010012398A1 Substituted pyridines, and use thereof as gsk3 inhibitors
02/04/2010WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor
02/04/2010WO2010012396A1 5,6 substituted benzamide derivatives as modulators of the ep<sb>2 </sb>receptor
02/04/2010WO2010012138A1 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimino)pyrrolidin-1-yl] quinoline carboxylic acid derivatives and methods for preparation
02/04/2010WO2009153569A3 Cb1 receptor modulators
02/04/2010WO2009149258A3 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
02/04/2010US20100029950 Novel substituted 1h-dihydropyrazoles, their preparation and use
02/04/2010US20100029947 Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them
02/04/2010US20100029946 Crystalline form of a benzimidazole-carboxamide medicinal compound
02/04/2010US20100029944 Process for the Synthesis of Solifenacin
02/04/2010US20100029942 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
02/04/2010US20100029941 Preparation of (r)-3-aminopiperidine dihydrochloride
02/04/2010US20100029939 Preparation of ketone amides
02/04/2010US20100029938 Process for the preparation of an antibacterial quinolone compound
02/04/2010US20100029936 Quinolone Carboxylic Acids, Derivatives Thereof, and Methods of Making and Using Same
02/04/2010US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
02/04/2010US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases
02/04/2010US20100029700 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitors
02/04/2010US20100029696 Indolylamino quinazoline derivatives as antitumor agents
02/04/2010US20100029690 Nitrogen-containing heterocyclic compounds
02/04/2010US20100029688 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment
02/04/2010US20100029687 Piperidine derivative or salt thereof
02/04/2010US20100029685 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
02/04/2010US20100029684 Pyrazinone Modulator of Corticotropin-Releasing Factor Receptor Activity
02/04/2010US20100029679 Antibacterial quinoline derivatives
02/04/2010US20100029671 Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders
02/04/2010US20100029651 Aryl-substituted heterocycles, and use thereof
02/04/2010US20100029650 Bicyclic compounds and use as antidiabetics
02/04/2010US20100029647 3,4,(5)-substituted tetrahydrophyridines
02/04/2010US20100029643 Heterocyclyc sulfonamides having edg-1 antagonistic activity
02/04/2010US20100029640 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
02/04/2010US20100029635 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
02/04/2010US20100029634 Chemokine Receptor Modulators
02/04/2010US20100029633 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
02/04/2010US20100029626 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
02/04/2010US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives
02/04/2010US20100029621 Hexafluoroisopropanol derivatives
02/04/2010US20100029620 Substituted triazoline, tetrazolone and imidazolone derivatives for use as a medicine
02/04/2010US20100029615 Benzimidazole derivatives
02/04/2010US20100029610 Heteroaryl Compounds and Uses Thereof
02/04/2010US20100029607 Substituted Piperazines as CB1 Antagonists
02/04/2010US20100029606 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
02/04/2010US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor
02/04/2010US20100029540 Biheteroaryl metal complexes as bleach catalysts
02/04/2010US20100029478 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
02/04/2010US20100026171 Condensed ring aromatic compound for organic light-emitting device and organic light-emitting device having the same
02/04/2010US20100025669 Amine-based compound, organic light emitting device comprising the amine-based compound, and flat panel display device including the organic light emitting device
02/04/2010US20100025661 Luminescent material and organic electroluminescent device using the same
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 1080